Search Results for:

Enzene Biosciences Teriparatide Biosimilar Obtains Marketing Authoriation in India

Enzene Biosciences Ltd., located in Pune, India, has announced that it has obtained marketing authorization from the Drug Controller General of India (DCGI) for its first biosimilar product in India. Enzene’s teriparatide biosimilar, indicated for the treatment of osteoporosis, will be marketed through Enzene’s holding company Alkem Laboratories, Ltd.

Read More

Biocon Biologics Expands Access to Biosimilars In Over 30 Countries In Africa and Asia

Biocon Biologics, a subsidiary of Biocon, announced today that it has signed an agreement with Clinton Health Access Initiative (CHAI) to develop advanced cancer therapies for patients in 25 countries in Africa and 5 countries in Asia as part of the Cancer Access Partnership (CAP). According to the announcement, Biocon Biologics aims…

Read More